V

Virax Biolabs Group Limited
D

VRAX

3.18500
USD
0.01
(0.16%)
قبل الجلسة·3.16000USD-0.02500(-0.78%)
حجم التداول
831
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
2,538,407
المقالات
المزيد

العنوان: Virax Biolabs Group Limited

القطاع: Healthcare
الصناعة: Biotechnology
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.